Results 261 to 270 of about 2,555,341 (310)

PAK1 activation drives divergent resistance mechanisms to aromatase inhibition and tamoxifen in a luminal: A breast cancer model

Molecular Oncology, EarlyView.
Breast cancer remains a major cause of cancer death in women, frequently developing endocrine therapy resistance. This study demonstrates that upregulated p21‐activated kinase 1 (PAK1) activity drives resistance to tamoxifen and long‐term estrogen deprivation in ER+ breast cancer models.
Luisa Schwarzmüller, Janina Müller, Efstathios‐Iason Vlachavas, Lukas Beumers, Lena Fleischhacker, Sara Burmester, Angelika Wörner, Sabine Karolus, Dominic Helm, Cindy Körner, Stefan Wiemann   +10 more
wiley   +1 more source

From Berry to Bedside: Translational Potential of Berry-Derived Phytochemicals in HNSCC. [PDF]

Molecules
Nyati KK, Ramalingam R, Shrestha S, Jagadeesha S, Dasari S, Masood S, Yade M, Mehta PA, Kundety S, Oghumu S.   +9 more
europepmc   +1 more source

Theoretical Perspectives on Balance Training and the Gut-Muscle-Brain Axis in Aging. [PDF]

Brain Sci
Zandi A, Burtscher J, Federolf P.
europepmc   +1 more source

Exploring the gut-brain axis: dietary influences on Alzheimer's disease pathogenesis. [PDF]

Front Microbiomes
Mansour SR, Khalaf MA, Moustafa MA, Moustafa MA, Moustafa AA.   +4 more
europepmc   +1 more source

The silent pharmacist: Harnessing the gut microbiome to improve therapy in hematologic malignancies. [PDF]

Transl Oncol
El-Sehrawy AAMA, Soleimani Samarkhazan H.   +1 more
europepmc   +1 more source

Cellular and Molecular Mechanisms Regulating Neuronal Function, Homeostasis, and Disease. [PDF]

Brain Sci
Sobral AF, Barbosa DJ.
europepmc   +1 more source